Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'tumor markers' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 977 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Seregni, E; Ferrari, L; Martinetti, A; Bombardieri, E
      Diagnostic and prognostic tumor markers in the gastrointestinal tract

      SEMINARS IN SURGICAL ONCOLOGY
    2. Keith, LG; Oleszczuk, JJ; Laguens, M
      Circadian rhythm chaos: A new breast cancer marker

      INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
    3. Brand, R
      The diagnosis of pancreatic cancer

      CANCER JOURNAL
    4. Gion, M; Peloso, L; Mione, R; Vignati, G; Fortunato, A; Saracchini, S; Biasioli, R; Gulisano, M; Cappelli, G
      Tumor markers in breast cancer monitoring should be scheduled according toinitial stage and follow-up time: A prospective study on 859 patients

      CANCER JOURNAL
    5. Bergquist, A; Broome, U
      Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    6. Pfister, M; Gottstein, B; Kretschmer, R; Cerny, T; Cerny, A
      Elevated carbohydrate antigen 19-9 (CA 19-9) in patients with Echinococcusinfection

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    7. Tuxen, MK; Soletormos, G; Petersen, PH; Dombernowsky, P
      Interpretation of sequential measurements of cancer antigen 125 (CA 125), carcinoembryonic antigen (CEA), and tissue polypeptide antigen (TPA) based on analytical imprecision and biological variation in the monitoring of ovarian cancer

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    8. Soletormos, G; Bach, F
      Tissue polypeptide-specific antigen (TPS) concentrations in cerebrospinal fluid in patients with breast cancer metastases in the central nervous system

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    9. Mohammed, MQ; Abraha, HD; Sherwood, RA; MacRae, K; Retsas, S
      Serum S100 beta protein as a marker of disease activity in patients with malignant melanoma

      MEDICAL ONCOLOGY
    10. Zusman, I; Ben-Hur, H
      Serological markers for detection of cancer (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    11. Hayes, DF; Yamauchi, H; Broadwater, G; Cirrincione, CT; Rodrigue, SP; Berry, DA; Younger, J; Panasci, LL; Millard, F; Duggan, DB; Norton, L; Henderson, IC
      Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and leukemia group B study 8662

      CLINICAL CANCER RESEARCH
    12. Guadagni, F; Ferroni, P; Carlini, S; Mariotti, S; Spila, A; Aloe, S; D'Alessandro, R; Carone, MD; Cicchetti, A; Ricciotti, A; Venturo, I; Perri, P; Di Filippo, F; Cognetti, F; Botti, C; Roselli, M
      A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study

      CLINICAL CANCER RESEARCH
    13. Soeth, E; Wirth, T; List, HJ; Kumbhani, S; Petersen, A; Neumaier, M; Czubayko, F; Juhl, H
      Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells

      CLINICAL CANCER RESEARCH
    14. Rodrigues, RG; Panizo-Santos, A; Cashel, JA; Krutzsch, HC; Merino, MJ; Roberts, DD
      Semenogelins are ectopically expressed in small cell lung carcinoma

      CLINICAL CANCER RESEARCH
    15. Hefler, LA; Tempfer, CB; Bancher-Todesca, D; Schatten, C; Husslein, P; Heinze, G; Gregg, AR
      Placental expression and serum levels of cytokeratin-18 are increased in women with preeclampsia

      JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION
    16. Orlandi, A; Piccione, E; Francesconi, A; Spagnoli, LG
      Simultaneous vulvar intraepithelial neoplasia and Paget's disease: Report of two cases

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    17. Becker, C; Noldus, J; Diamandis, E; Lilja, H
      The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease

      CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
    18. Duffy, MJ
      Clinical uses of tumor markers: A critical review

      CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
    19. Canizares, F; Sola, J; Perez, M; Tovar, I; De Las Heras, M; Salinas, J; Penafiel, R; Martinez, P
      Preoperative values of CA 15-3 and CEA as prognostic factors in breast cancer: A multivariate analysis

      TUMOR BIOLOGY
    20. Norum, LF; Sauren, AM; Rye, PD; Nustad, K
      New immunoassays for MUC1 in breast cancer

      TUMOR BIOLOGY
    21. Rye, PD; McGuckin, MA
      MUC1: Antibodies and immunoassays

      TUMOR BIOLOGY
    22. Stigbrand, T
      The versatility of cytokeratins as tumor markers

      TUMOR BIOLOGY
    23. Miedouge, M; Devys, A; Simon, M; Rouzaud, P; Salama, G; Reyre, J; Pujazon, MC; Carles, P; Serre, G
      High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1,2, 10/11, 14 or filaggrin in the serum of squamous cell lung carcinoma patients

      TUMOR BIOLOGY
    24. Zheng, CX; Zhan, WH; Zhao, JZ; Zheng, D; Wang, DP; He, YL; Zheng, ZQ
      The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer

      WORLD JOURNAL OF GASTROENTEROLOGY
    25. Darwish, AM; Amin, AF; AbdelAleem, MA; Youssef, MA
      Laparoscopic management of benign adnexal masses: experience in a developing country

      GYNAECOLOGICAL ENDOSCOPY
    26. Gion, M; Mione, R; Leon, AE; Luftner, D; Molina, R; Possinger, K; Robertson, JF
      CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases

      EUROPEAN JOURNAL OF CANCER
    27. Whitlock, JPL; Evans, AJ; Jackson, L; Chan, SY; Robertson, JFR
      Imaging of metastatic breast cancer: Distribution and radiological assessment at presentation

      CLINICAL ONCOLOGY
    28. Cordon-Cardo, C
      Applications of molecular diagnostics: Solid tumor genetics can determine clinical treatment protocols

      MODERN PATHOLOGY
    29. Schneider, DT; Calaminus, G; Gobel, U
      Diagnostic value of alpha(1)-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    30. Tramonti, G; Ferdeghini, M; Annichiarico, C; Norpoth, M; Donadio, C; Bianchi, R; Bianchi, C
      Relationship between renal function and blood level of chromogranin A

      RENAL FAILURE
    31. Engaras, B; Kewenter, J; Nilsson, O; Wedel, H; Hafstrom, L
      CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    32. Mendoza, CE; Rosado, MF; Bernal, L
      The role of interleukin-6 in cases of cardiac myxoma - Clinical features, immunologic abnormalities, and a possible role in recurrence

      TEXAS HEART INSTITUTE JOURNAL
    33. Frena, A
      SPan-1 and exocrine pancreatic carcinoma. The clinical role of a new tumormarker

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    34. Thomas, CMG; Sweep, CGJ
      Serum tumor markers: past, state of the art, and future

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    35. Giovanella, L; Ceriani, L; Bandera, M; Garancini, S
      Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    36. Indinnimeo, M; Cicchini, C; Stazi, A; Ghini, C; Mingazzini, P; Laghi, A
      Analysis of a follow-up program for anal canal carcinoma

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    37. Appetecchia, M; Mecule, A; Ducci, M; Palma, L; Castelli, M
      Serum cytokeratins determination in differentiated thyroid carcinoma

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    38. Ganger, DR; Hamilton, PD; Klos, DJ; Jakate, S; McChesney, L; Fernandez-Pol, JA
      Differential expression of metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia

      CANCER DETECTION AND PREVENTION
    39. Yasumatsu, R; Nakashima, T; Azuma, K; Hirakawa, N; Kuratomi, Y; Tomita, K; Cataltepe, S; Silverman, GA; Clayman, GL; Komiyama, S
      SCCA1 expression in T-lymphocytes peripheral to cancer cells is associatedwith the elevation of serum SCC antigen in squamous cell carcinoma of the tongue

      CANCER LETTERS
    40. Kausch, I; Bohle, A
      Bladder cancer II. Molecular aspects and diagnosis

      EUROPEAN UROLOGY
    41. Loggini, B; Rinaldi, I; Pingitore, R; Cristofani, R; Castagna, M; Barachini, P
      Immunohistochemical study of 49 cutaneous melanomas: p53, PCNA, Bcl-2 expression and multidrug resistance

      TUMORI
    42. Patel, T
      Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

      HEPATOLOGY
    43. Spila, A; Ferroni, P; Cosimelli, M; D'Alessandro, R; Abbolito, MR; Mariotti, S; Aloe, S; Carone, MD; Graziano, F; Tedesco, M; Martin, F; Mancini, R; Stigliano, V; Roselli, M; Guadagni, F
      Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation

      ANTICANCER RESEARCH
    44. Ros-Bullon, MR; Sanchez-Pedreno, P; Martinez-Liarte, H
      Serum ceruloplasmin in melanoma patients

      ANTICANCER RESEARCH
    45. Hu, XC; Chow, LWC
      Detection of circulating breast cancer cells with multiple-marker RT-PCR assay

      ANTICANCER RESEARCH
    46. Stulik, J; Hernychova, L; Porkertova, S; Knizek, J; Macela, A; Bures, J; Jandik, P; Langridge, JI; Jungblut, PR
      Proteome study of colorectal carcinogenesis

      ELECTROPHORESIS
    47. Kiba, T; Numata, K; Kirikoshi, H; Kamijo, S; Nakatani, Y; Sekihara, H
      A long-term survival case of pancreatic poorly differentiated adenocarcinoma with transcatheter arterial embolization and combination chemotherapy

      HEPATO-GASTROENTEROLOGY
    48. Torzilli, G; Inoue, K; Midorikawa, Y; Hui, AM; Takayama, T; Makuuchi, M
      Inflammatory pseudotumors of the liver: Prevalence and clinical impact in surgical patients

      HEPATO-GASTROENTEROLOGY
    49. Wollina, U; Hipler, UC; Knoll, B; Graefe, T; Kaatz, M; Kirsch, K
      Serum matrix metalloproteinase-2 in patients with malignant melanoma

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    50. Alatas, F; Alatas, O; Metintas, M; Colak, O; Harmanci, E; Demir, S
      Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions

      LUNG CANCER
    51. Kasimir-Bauer, S; Oberhoff, C; Sliwinska, K; Neumann, R; Schindler, AE; Seeber, S
      Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use ?

      BREAST CANCER RESEARCH AND TREATMENT
    52. D'Alessandro, R; Roselli, M; Ferroni, P; Mariotti, S; Spila, A; Aloe, S; Carone, MD; Abbolito, MR; Carlini, S; Perri, P; Ricciotti, A; Botti, C; Conti, F; Vici, P; Chiappetta, NR; Cognetti, F; Buonomo, O; Guadagni, F
      Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    53. Manhani, AR; Manhani, R; Soares, HP; Bendit, I; Lopes, F; Nicoletti, AGB; Fonseca, FLA; Novaes, M; Zatta, SM; Arias, V; Giralt, S; del Giglio, A
      CK-19 expression by RT-PCR in the peripheral blood of breast cancer patients correlates with response to chemotherapy

      BREAST CANCER RESEARCH AND TREATMENT
    54. Desai, DC; O'Dorisio, TM; Schirmer, WJ; Jung, SS; Khabiri, H; Villanueva, V; Martin, EW
      Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors

      REGULATORY PEPTIDES
    55. Lamberts, SWJ; Hofland, LJ; Nobels, FRE
      Neuroendocrine tumor markers

      FRONTIERS IN NEUROENDOCRINOLOGY
    56. Simojoki, M; Santala, M; Risteli, J; Kauppila, A
      Carboxyterminal telopeptide of type I collagen (ICTP) in predicting prognosis in epithelial ovarian cancer

      GYNECOLOGIC ONCOLOGY
    57. Becker, T; Hegele, A; Varga, Z; Schwetlick, I; Heidenreich, A; Hofmann, R
      Alpha-fetoprotein-producing gastric cancer mimicking extragonadal testicular cancer

      UROLOGIA INTERNATIONALIS
    58. Deschenes, M; Michel, RP; Alpert, E; Barkun, JS; Metrakos, P; Tchervenkov, J
      Elevation of CA-125 level is due to abdominal distension in liver transplantation candidates

      TRANSPLANTATION
    59. Johne, B; Kronborg, O; Ton, HI; Kristinsson, J; Fuglerud, P
      A new fecal calprotectin test for colorectal neoplasia - Clinical results and comparison with previous method

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    60. Kristinsson, J; Armbruster, C; Ugstad, M; Kriwanek, S; Nygaard, K; Ton, H; Fuglerud, P
      Fecal excretion of calprotectin in colorectal cancer - Relationship to tumor characteristics

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    61. Yao, WJ; Chang, TT; Wang, ST; Chow, NH; Lin, PW; Chang, YC; Tu, DG; Chiu, NT
      Clinicopathologic correlation of serum tissue polypeptide specific antigenin hepatocellular carcinoma

      ONCOLOGY
    62. De Pinieux, G; Flam, T; Zerbib, M; Taupin, P; Bellahcene, A; Waltregny, D; Vieillefond, A; Poupon, MF
      Bone sialoprotein, bone morphogenetic protein 6 and thymidine phosphorylase expression in localized human prostatic adenocarcinoma as predictors of clinical outcome: A clinicopathological and immunohistochemical study of 43 cases

      JOURNAL OF UROLOGY
    63. Bernardini, S; Fauconnet, S; Chabannes, E; Henry, PC; Adessi, G; Bittard, H
      Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer

      JOURNAL OF UROLOGY
    64. Shi, Y; Brands, FH; Chatterjee, S; Feng, AC; Groshen, S; Schewe, J; Lieskovsky, G; Cote, RJ
      HER-2/neu expression in prostate cancer: High level of expression associated with exposure to hormone therapy and androgen independent disease

      JOURNAL OF UROLOGY
    65. Cassel, A; Rahat, MA; Lahat, N; Lindenfeld, N; Mecz, Y; Stein, A
      Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: An unfulfilled promise

      JOURNAL OF UROLOGY
    66. Yu, DS; Hsieh, DS; Chen, HI; Chang, SY
      The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications

      JOURNAL OF UROLOGY
    67. Noguchi, M; Noda, S
      Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer

      JOURNAL OF UROLOGY
    68. Epstein, JI; Potter, SR
      The pathological interpretation and significance of prostate needle biopsyfindings: Implications and current controversies

      JOURNAL OF UROLOGY
    69. Giannopoulos, A; Manousakas, T; Gounari, A; Constantinides, C; Choremi-Papadopoulou, H; Dimopoulos, C
      Comparative evaluation of the diagnostic performance of the BTA stat test,NMP22 and urinary bladder cancer antigen for primary and recurrent bladdertumors

      JOURNAL OF UROLOGY
    70. Ponsky, LE; Sharma, S; Pandrangi, L; Kedia, S; Nelson, D; Agarwal, A; Zippe, CD
      Screening and monitoring for bladder cancer: Refining the use of NMP22

      JOURNAL OF UROLOGY
    71. Hautmann, SH; Lokeshwar, VB; Schroeder, GL; Civantos, F; Duncan, RC; Gnann, R; Friedrich, MG; Soloway, MS
      Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer

      JOURNAL OF UROLOGY
    72. Isola, J; Auvinen, A; Poutiainen, M; Kakkola, L; Jarvinen, TAH; Maattanen, L; Stenman, UH; Tammela, T; Hakama, M; Visakorpi, T
      Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer

      JOURNAL OF UROLOGY
    73. Lokeshwar, VB; Soloway, MS
      Current bladder tumor tests: Does their projected utility fulfill clinicalnecessity?

      JOURNAL OF UROLOGY
    74. Naughton, M; Picus, J; Zhu, XP; Catalona, WJ; Vollmer, RT; Humphrey, PA
      Scatter factor-hepatocyte growth factor elevation in the serum of patientswith prostate cancer

      JOURNAL OF UROLOGY
    75. Raitanen, MP; Marttila, T; Nurmi, M; Ala-Opas, M; Nieminen, P; Aine, R; Tammela, TLJ; Group, F
      Human complement factor H related protein test for monitoring bladder cancer

      JOURNAL OF UROLOGY
    76. Duraker, N; Celik, AN
      The prognostic significance of preoperative sevum CA 19-9 in patients withresectable gastric carcinoma: Comparison with CEA

      JOURNAL OF SURGICAL ONCOLOGY
    77. Manzotti, M; Dell'Orto, P; Maisonneuve, P; Zurrida, S; Mazzarol, G; Viale, G
      Reverse transcription-polymerase chain reaction assay for multiple mrna markers in the detection of breast cancer metastases in sentinel lymph nodes

      INTERNATIONAL JOURNAL OF CANCER
    78. Das, B; Tao, SZ; Mushnitsky, R; Norin, AJ
      Genetic identity and differential expression of p38.5 (Haymaker) in human malignant and nonmalignant cells

      INTERNATIONAL JOURNAL OF CANCER
    79. Lukes, M; Urban, M; Zalesky, M; Zachoval, R; Heracek, J; Zdarsky, E
      Prostate-specific antigen: Current status

      FOLIA BIOLOGICA
    80. Errico, DA; Medeiros, A; Miguez, M; Casaravilla, C; Malgor, R; Carmona, C; Nieto, A; Osinaga, E
      O-glycosylation in Echinococcus granulosus: Identification and characterization of the carcinoma-associated Tn antigen

      EXPERIMENTAL PARASITOLOGY
    81. Paganuzzi, M; Onetto, M; Marroni, P; Filiberti, R; Tassara, E; Parodi, S; Felletti, R
      Diagnostic value of CYFRA 21-1 turner marker end CEA in pleural effusion due to mesothelioma

      CHEST
    82. Baker, VV
      Treatment options for ovarian cancer

      CLINICAL OBSTETRICS AND GYNECOLOGY
    83. Duffy, MJ
      Biochemical markers in breast cancer: which ones are clinically useful?

      CLINICAL BIOCHEMISTRY
    84. Sturgeon, CM
      Tumor markers in the laboratory: closing the guideline-practice gap

      CLINICAL BIOCHEMISTRY
    85. Poon, TCW; Johnson, PJ
      Proteome analysis and its impact on the discovery of serological tumor markers

      CLINICA CHIMICA ACTA
    86. Luo, LY; Bunting, P; Scorilas, A; Diamandis, EP
      Human kallikrein 10: a novel tumor marker for ovarian carcinoma?

      CLINICA CHIMICA ACTA
    87. Yousef, GM; Kyriakopoulou, LG; Scorilas, A; Fracchioli, S; Ghiringhello, B; Zarghooni, M; Chang, A; Diamandis, M; Giardina, G; Hartwick, WJ; Richiardi, G; Massobrio, M; Diamandis, EP; Katsaros, D
      Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: A new independent and favorable prognostic marker

      CANCER RESEARCH
    88. Ardizzoni, A; Cafferata, MA; Paganuzzi, M; Filiberti, R; Marroni, P; Neri, M; Fontana, V; Nicolo, G; Perdelli, L; Stampino, CG; Rosso, R; Puntoni, R
      Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma

      CANCER
    89. Daling, JR; Malone, KE; Doody, DR; Johnson, LG; Gralow, JR; Porter, PL
      Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma

      CANCER
    90. Joseph, MG; Banerjee, D; Kocha, W; Feld, R; Stitt, LW; Cherian, MG
      Metallothionein expression in patients with small cell carcinoma of the lung - Correlation with other molecular markers and clinical outcome

      CANCER
    91. Katopodis, N; Glantz, MJ; Kim, L; Dafni, U; Wu, JK; Perides, G
      Lipid-associated sialoprotein in the cerebrospinal fluid - Association with brain malignancies

      CANCER
    92. Castro, MP; McDonald, TJ; Qualman, SJ; Odorisio, TM
      Cerebrospinal fluid gastrin releasing peptide in the diagnosis of leptomeningeal metastases from small cell carcinoma

      CANCER
    93. Pichon, MF; Basuyau, JP; Gory-Delabaere, G; Eche, N; Daver, A; Blanc-Vincent, MP; Riedinger, JM; Deneux, L; Bidart, JM
      Standards, Options and Recommendations for tumor markers in thyroid cancers

      BULLETIN DU CANCER
    94. Ychou, M; Khemissa-Akouz, F; Kramer, A; Senesse, P; Grenier, J
      A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma

      BULLETIN DU CANCER
    95. Price, CP; Allard, J; Davies, G; Dawnay, A; Duffy, MJ; France, M; Mandarino, G; Ward, AM; Patel, B; Sibley, P; Sturgeon, C
      Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer

      ANNALS OF CLINICAL BIOCHEMISTRY
    96. Zaher, A; Sheridan, T
      Tumor markers in the detection of recurrent transitional cell carcinoma ofthe bladder - A brief review

      ACTA CYTOLOGICA
    97. Barth, Z; Kohler, B
      An unusual cause of malignant ascites - Peritoneal mesothelioma - Reply

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    98. Jones, D; Dang, NH; Duvic, M; Washington, LT; Huh, YO
      Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood

      AJCP. American journal of clinical pathology
    99. Holschneider, CH; Berek, JS
      Ovarian cancer: Epidemiology, biology, and prognostic factors

      SEMINARS IN SURGICAL ONCOLOGY
    100. Sagae, S; Kudo, R
      Surgery for germ cell tumors

      SEMINARS IN SURGICAL ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 06:17:00